Mcdermott Will & Emery LLP recently issued the following announcement.
Through the groundbreaking creation and rapid development of cutting-edge diagnostic and treatments solutions that significantly improve patient outcomes for cancer and other conditions, precision medicine has, and will continue to, dramatically transform healthcare.
Effective partnerships and other collaborations have become essential to advancing the new approaches precision health offers. In the second program of our Precision Health series, our panelists will use real-world scenarios to explore:
- The strategic, financial, legal and regulatory compliance challenges that arise in the formation and implementation of such partnerships and other collaborations, including privacy, fraud and abuse, and reimbursement regulatory challenges, and
- Alternative strategies for managing such challenges at the formation stage and throughout the lifecycle of both the collaboration and the particular innovation on which the collaboration is focused
Date: July 21, 2021
Original source can be found here.